Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

VectivBio Holding AG - Ordinary Shares (NQ:VECT)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 16.01 (53)
Ask (Size) 16.96 (200)
Prev. Close 16.85
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
From VectivBio AG
Via GlobeNewswire

Performance

More News

Read More
Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
What 4 Analyst Ratings Have To Say About VectivBio Holding
Via Benzinga
Piper Sandler Maintains Overweight Rating for VectivBio Holding: Here's What You Need To Know
Via Benzinga
Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround
Via The Motley Fool
VECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG - VECT
From Kahn Swick & Foti, LLC
Via Business Wire
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Via Investor's Business Daily
VECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG - VECT
From Kahn Swick & Foti, LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Via Benzinga
Why Ironwood Pharmaceuticals Stock Bumped Higher Today
Via The Motley Fool
Ironwood Scoops Up Gastrointestinal Diseases Player For $1B
Via Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Shares of VectivBio Holding Are Up Today
Via The Motley Fool
Merger Monday
Via Talk Markets
Why VectivBio Shares Are Surging Monday
Via Benzinga
US Stocks Mixed; Nordic American Tankers Posts Upbeat Results
Via Benzinga
VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion
Via Investor's Business Daily
Benzinga Pro's Top 5 Stocks To Watch For Monday, May 22, 2023: MU, RKT, DLTR, LDOS, IRWD
Via Benzinga
VECT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of VectivBio Holding AG Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
VectivBio Publishes Invitation to the Annual General Meeting
From VectivBio AG
Via GlobeNewswire
VectivBio Reports Full Year 2022 Financial Results and Provides Business Update
From VectivBio AG
Via GlobeNewswire
VectivBio to Report Full Year 2022 Financial Results and Provide Business Update on Wednesday, April 19, 2023
From VectivBio AG
Via GlobeNewswire
VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan
From VectivBio AG
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
Via Benzinga

Frequently Asked Questions

Is VectivBio Holding AG - Ordinary Shares publicly traded?
Yes, VectivBio Holding AG - Ordinary Shares is publicly traded.
What exchange does VectivBio Holding AG - Ordinary Shares trade on?
VectivBio Holding AG - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for VectivBio Holding AG - Ordinary Shares?
The ticker symbol for VectivBio Holding AG - Ordinary Shares is VECT on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.